JAMES HALL: Open Payments
NPI 1679888119 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 6 payments from 4 companies in 2025. Trend: 2023 $130 · 2024 $66 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| ABBVIE INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: CAPLYTA, AIRSUPRA, VIBERZI, Quviviq, MAVYRET.
Industry payments across KY — which companies pay providers there.
